CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 122 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $122,601,000 | -32.6% | 6,051,376 | 0.0% | 10.00% | -34.2% |
| Q2 2020 | $181,844,000 | -4.4% | 6,051,376 | 0.0% | 15.21% | -36.8% |
| Q1 2020 | $190,195,000 | -32.8% | 6,051,376 | +0.7% | 24.08% | -28.8% |
| Q4 2019 | $283,117,000 | +629.3% | 6,009,702 | 0.0% | 33.81% | +180.2% |
| Q3 2019 | $38,822,000 | -32.4% | 6,009,702 | +28.5% | 12.06% | -26.5% |
| Q2 2019 | $57,446,000 | -9.4% | 4,677,939 | 0.0% | 16.42% | -51.4% |
| Q1 2019 | $63,386,000 | +237.9% | 4,677,939 | +0.0% | 33.76% | +104.2% |
| Q4 2018 | $18,759,000 | – | 4,677,938 | – | 16.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |